Company news
Peptidream Inc. news in 2024
Peptidream Inc.'s news releases, calls and decks from 2024, newest first.
PeptiDream Announces Second Internal Peptide Radiopharmaceutical Therapeutic Program Targeting Claudin 18.2 for the Potential Diagnosis and Treatment of Gastric Cancer
December 12, 2024
PeptiDream Announces Preclinical Results Demonstrating Efficacy of Oral Myostatin Inhibitors in Preventing Loss of Lean Mass Associated with Semaglutide Treatment
December 12, 2024
NCC and PeptiDream Announce the First Dosing of 64Cu-PD-32766 in a patient with Clear Cell Renal Cell Carcinoma
June 4, 2024
PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis
April 30, 2024